Austrian Biotech Industry (ABI) represents about 95 % of the Austrian valuecreation in the field of biotechnology.
The membership comprises as well-established companies in the field of biotechnology as young start-up companies.
The main fields of activity within the biotechnologies sectors are:
(Intercell) Intercell acquires antibody technology platform to further exploit its capabilities to combat infectious diseases mehr
(Apeptico) APEPTICO granted Orphan Drug Designation by FDA for development compound AP301 mehr